ASCP Commends Congressional Action to Expand Medicare Access to Pharmacist Services
ALEXANDRIA, VA / ACCESS Newswire / May 21, 2026 / The American Society of Consultant Pharmacists (ASCP) commends the House...
Vaccine
Propanc Biopharma Engages European CDMO for GMP Production of PRP for Phase 1b, FIH Study in 30 – 40 Advanced Cancer Patients
Provides End-To-End Services for Preclinical & Clinical Projects with Extensive Experience in Decoding Biologics ProductionMELBOURNE, Australia, May 19, 2026 (GLOBE...
Ebola Global Health Emergency Needs a Broad-Spectrum Drug – NV-387 is a Strong Potential Candidate, Says NanoViricides
SHELTON, CT / ACCESS Newswire / May 18, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader...
Emergent BioSolutions Receives Saudi Food and Drug Authority Approval for ACAM2000® [Smallpox and Mpox (Vaccinia) Vaccine, Live]
GAITHERSBURG, Md., May 18, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions (NYSE:EBS), a global biodefense company, today announced that the Saudi...
NanoViricides, Inc. Has Filed its Quarterly Report – NV-387 Advancing for Phase II
SHELTON, CT / ACCESS Newswire / May 15, 2026 / NanoViricides, Inc. (NYSE Amer.:NNVC) (the "Company"), reports that it has...
Biogen Completes Acquisition of Apellis Pharmaceuticals
CAMBRIDGE, Mass., May 14, 2026 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) today announced the successful completion of the acquisition...
Congress Orders DEA Crackdown on Intoxicating Cannabinoids While CMS Continues Expanding Medicare CBD Access
"As Federal Courts Review the Legality of the CMS BEI Program, Washington's Cannabinoid Policy Is Colliding With Itself" stated Duane...
Moderna Recognized by TIME as One of the World’s Most Impactful Companies
CAMBRIDGE, MA / ACCESS Newswire / May 12, 2026 / Moderna, Inc. (NASDAQ:MRNA) today announced it was ranked no. 1...
IMUNON Reports First Quarter 2026 Financial Results and Provides Business Update
IMNN-001 is the First and Only frontline treatment candidate to demonstrate the potential for a clinically meaningful overall survival benefit...
Recent Hantavirus On A Cruise Ship Highlights the Need for Broad-Spectrum Antiviral Drugs Such as NV-387, Says NanoViricides
SHELTON, CT / ACCESS Newswire / May 11, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader...
2026 Children’s Hospital Digital Technology Leaders Named as Pediatric Providers Shift IT Spending From Innovation to Operating Protection
Black Book Research's new 87-page, 11 month long pediatric technology study names 2026 category leaders across EHR, AI documentation, revenue...
FDA Grants Seventh Approval under the National Priority Voucher Pilot Program
White Oak, Md., May 08, 2026 (GLOBE NEWSWIRE) -- The U.S. Food and Drug Administration today issued an approval for...
Alpha Pro Tech, Ltd. Announces First Quarter 2026 Financial Results
First Quarter Net Sales Increased by 5.5% to $14.6 Million, Compared to $13.8 Million for the First Quarter of 2025...
Moderna Announces New England Journal of Medicine Publication of Pivotal Phase 3 Clinical Safety and Efficacy Data for Its Investigational Seasonal Influenza Vaccine, mRNA-1010
Regulatory filings are under review in the U.S., Europe, Canada and Australia, with potential approvals expected to begin in 2026...
IMUNON to Hold First Quarter 2026 Financial Results and Business Update Conference Call on Tuesday, May 12, 2026
LAWRENCEVILLE, N.J., May 05, 2026 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage company in late-stage development with its...
Altrova Health Announces Launch of O-Spray Product Line and Provides Corporate Update
Toronto, Ontario--(Newsfile Corp. - May 5, 2026) - Altrova Health Inc. (CSE: ROVA) (OTCQB: SSPLF) (FSE: QM4) ("Altrova Health" or...
Altrova Health Announces Launch of O-Spray Product Line and Provides Corporate Update
Toronto, Ontario--(Newsfile Corp. - May 5, 2026) - Altrova Health Inc. (CSE: ROVA) (OTCQB: SSPLF) (FSE: QM4) ("Altrova Health" or...
NV-387 for The Treatment of Measles is Granted Orphan Drug Designation by The US FDA
SHELTON, CT / ACCESS Newswire / May 4, 2026 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the "Company"),...
Moderna Reports First Quarter 2026 Financial Results and Provides Business Updates
Reports first quarter revenue of $0.4 billion, with approximately 80% of revenue from international marketsReports first quarter GAAP net loss...
Tonix Pharmaceuticals Announces Presentation of Phase 1 Data and Plans for an Adaptive Phase 2 Field Study of TNX-4800 (anti-Borrelia OspA monoclonal antibody) for the Prevention of Lyme Disease at the 4th Annual Ticks and Tickborne Diseases Symposium at Johns Hopkins University
Company on track to initiate a randomized, double-blind, placebo-controlled, adaptive Phase 2 field study in the first half of 2027,...